SUMO2 and nasopharyngeal carcinoma: Mo et al. found that upregulated SUMO2 promotes SLC2A1 degradation through sumo- and ubiquitination of SLC2A1, which leads to the proliferation and metastasis of nasopharyngeal carcinoma (Chen et al., 2021b).